These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1433420)

  • 1. Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.
    Wu HM
    J Tongji Med Univ; 1992; 12(2):65-70. PubMed ID: 1433420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
    De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
    Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.
    Joensuu H; Klemi PJ; Jalkanen S
    Cancer; 1990 Jun; 65(11):2564-71. PubMed ID: 2337874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
    Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
    J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
    Cowan RA; Harris M; Jones M; Crowther D
    Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency.
    McDunn SH; Winter JN; Variakojis D; Rademaker AW; Von Roenn JH; Tallman MS; Gordon LI; Bauer KD
    J Clin Oncol; 1991 Aug; 9(8):1334-40. PubMed ID: 1677032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma.
    Joensuu H; Klemi PJ; Söderström KO; Jalkanen S
    Cancer; 1991 Oct; 68(7):1564-71. PubMed ID: 1893358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
    Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
    Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA aneuploidy and cell proliferation in relation to histology and prognosis in patients with Hodgkin's disease.
    Erdkamp FL; Breed WP; Schouten HC; Janssen WC; Hoffmann JJ; Wijnen JT; Blijham GH
    Ann Oncol; 1993 Jan; 4(1):75-80. PubMed ID: 8435368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma.
    Christensson B; Lindemalm C; Johansson B; Mellstedt H; Tribukait B; Biberfeld P
    Leuk Res; 1989; 13(4):307-14. PubMed ID: 2716347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy, proliferative activities, and immunophenotype of malignant lymphoma: application of flow cytometry.
    Horii A; Yoshida J; Hattori K; Honjo Y; Mitani K; Takashima S; Sakai M; Okamoto S; Kubo T
    Head Neck; 1998 Aug; 20(5):392-8. PubMed ID: 9663666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
    Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
    Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of DNA ploidy in large cleaved cell lymphomas.
    Aine R; Lehtinen T; Lehtinen M; Blanco G; Apaja-Sarkkinen M; Leinikki P; Alavaikko M
    Hematol Oncol; 1990; 8(6):339-46. PubMed ID: 2286357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Flowcytometry DNA analysis of oral and maxillofacial non-Hodgkin's lymphoma].
    Ma L; He Z; Wu L; Cai Y; Huang H; Lei S
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2002 Jun; 20(3):193-6. PubMed ID: 12600064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
    Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas.
    Macartney JC; Camplejohn RS; Alder J; Stone MG; Powell G
    J Clin Pathol; 1986 May; 39(5):542-6. PubMed ID: 3722408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.
    Palestro G; Pich A; Chiusa L; Geuna M; Ponti R; Kerim S; Novero D; Valente G
    Leuk Lymphoma; 1995 Nov; 19(5-6):467-72. PubMed ID: 8590848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA content and prognosis of non-Hodgkin's lymphoma.
    Morgan DR; Williamson JM; Quirke P; Clayden AD; Smith ME; O'Brien CJ; Allison DL; Child JA; Bird CC
    Br J Cancer; 1986 Oct; 54(4):643-9. PubMed ID: 3778806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: a flow cytometry study using archival material.
    Young GA; Hedley DW; Rugg CA; Iland HJ
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1497-504. PubMed ID: 3678313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.